Sheraz Daya | |
---|---|
Occupation | Ophthalmologist |
Sheraz Daya is a British ophthalmologist. Daya founded the Centre for Sight in 1996, and works in stem-cell research and sight restoration and correction surgery.
Sheraz Daya first became interested in becoming an ophthalmologist in his grade school days after seeing a television documentary about corneal surgery. In 1982, midway through his medical studies, he decided to focus on opthalmology after watching an eye surgery performed by Peter Eustace, one of his professors. [1] Daya graduated from the Royal College of Surgeons in Ireland in 1984. [2] Following this, he interned at the Royal Victoria Hospital, Belfast [3] and from 1985 to 1988 he was a resident in internal medicine at the NY Downtown Hospital in New York. [4] He later specialized in Ophthalmology in New York and a Fellowship in Cornea, Keratorefractive and Anterior Segment Surgery at the University of Minneapolis, Minnesota. [3]
Daya began his career in New York City, where he served as director of cornea and external disease at the Catholic Medical Centre. In 1993, Daya became the director and consultant ophthalmic surgeon of the Corneo Plastic Unit and Eye Bank at the Queen Victoria Hospital NHS Trust in East Grinstead. [2] [5] In 1995 Daya was one of the first ophthalmologists to perform LASIK eye surgery in the UK. [6] In 1996 Daya founded the Centre for Sight, where he serves as director, [7] [8] which opened in 1996. [6] An article written about himself and the clinic after its 25th anniversary wrote that over the years the clinic has become “a reference centre for the Ophthalmic industry with international visitors regularly visiting to observe new technology.” [9] Through this, he has also worked in the fields of anterior segment and keratorefractive surgery, [5] and the use of femtosecond laser during cataract surgery in the NHS. [10]
Daya has also used stem cell treatment during corneal transplant surgeries, [11] [12] [13] and was the world's first person to perform live corneal transplantation with a femtosecond laser in 2006. [14] The technique of stem cell transplantaction was shown in the documentary film The Science of Seeing Again. [2] In 2009 Daya delivered the Choyce Medal lecture to the United Kingdom & Ireland Society of Cataract & Refractive Surgeons. [5] He has been able to treat patients with both sight decrease and those with previously permanently non-functioning eyes due to birth defects. [15] His patients have included public figures including presidents, prime ministers, and members of royal families. [9]
In 2012 Daya and his team performed restorative surgery on television personality Katie Piper, who had suffered blindness following an acid attack. [16] Daya has also been interviewed regarding other trends in ophthalmology [17] and methods of sight restoration. [18] [19] In 2017 Daya was shown in a BBC documentary providing advice on how laser eye surgery is supposed to be performed. [20] In the 2019 Daya transitioned his transplant technology to involve the placement of only a small fragment of donated corneal tissue to the eye of patients with more minor vision problems, which alleviated the need for lower prescription glasses like reading glasses. It was initially subject to a human trial with 100 subjects in partnership with the US company Allotex. He has also worked as a consultant to biotech firms including Bausch & Loeb. [21] In 2023 he was appointed to the Board of Orbis UK. [22] He is President-elect of the American-European Congress of Ophthalmic Surgery and will take up presidency in June 2024. [23]
Daya has served as co-Medical Editor of the journal Cataract & Refractive Surgery Today Europe. [5] He has also been published in the journal Ophthalmology , [24] [25] [26] [27] as well as in the journals Cornea, [28] [29] [30] the British Journal of Ophthalmology , [31] [32] and the Journal of Cataract & Refractive Surgery. [33] [34] Daya has also been published in the Journal of American Association for Pediatric Ophthalmology and Strabismus [35] and Transactions of the American Ophthalmological Society . [36] He has also penned pieces for the mainstream media, including The Guardian. [37]
In 2008 Daya received the Leadership for Improvement award from the National Health Service's South East Coast Best of Health and Health and Social Care Awards [38] [39] Then in 2009, Daya received the Senior Achievement Award from the American Academy of Ophthalmology [40] and the Choyce Medal from the United Kingdom & Ireland Society of Cataract & Refractive Surgeons. [5] [41] In 2017 he delivered the Whitney Sampson Lecture at the American Academy of Ophthalmology. [42] In 2018 Daya was awarded the Fyodorov medal by the Hellenic Society of Intraocular Implant and Refractive Surgery. [43] That year he was also named to The Power List, which is released annually by The Ophthalmologist magazine, and was named to the list in 2019 and 2020 as well. [44] In 2022 he was the recipient of a Lifetime Achievement Award from the International Society of Refractive Surgery. [45]
Daya is married to Marcela Espinosa-Lagana, who is also a medical doctor. [46]
Keratoconus (KC) is a disorder of the eye that results in progressive thinning of the cornea. This may result in blurry vision, double vision, nearsightedness, irregular astigmatism, and light sensitivity leading to poor quality-of-life. Usually both eyes are affected. In more severe cases a scarring or a circle may be seen within the cornea.
Far-sightedness, also known as long-sightedness, hypermetropia, and hyperopia, is a condition of the eye where distant objects are seen clearly but near objects appear blurred. This blur is due to incoming light being focused behind, instead of on, the retina due to insufficient accommodation by the lens. Minor hypermetropia in young patients is usually corrected by their accommodation, without any defects in vision. But, due to this accommodative effort for distant vision, people may complain of eye strain during prolonged reading. If the hypermetropia is high, there will be defective vision for both distance and near. People may also experience accommodative dysfunction, binocular dysfunction, amblyopia, and strabismus. Newborns are almost invariably hypermetropic, but it gradually decreases as the newborn gets older.
LASIK or Lasik, commonly referred to as laser eye surgery or laser vision correction, is a type of refractive surgery for the correction of myopia, hyperopia, and astigmatism. LASIK surgery is performed by an ophthalmologist who uses a femtosecond laser or a microkeratome to create a corneal flap to expose the corneal stroma and then an excimer laser to reshape the corneal stroma in order to improve visual acuity.
A microkeratome is a precision surgical instrument with an oscillating blade designed for creating the corneal flap in LASIK or ALK surgery. The normal human cornea varies from around 500 to 600 μm in thickness; and in the LASIK procedure, the microkeratome creates an 83 to 200 μm thick flap. The microkeratome uses an oscillating blade system, which has a blade that oscillates horizontally as the blade travels vertically for a precise cut. This piece of equipment is used all around the world to cut the cornea flap. The microkeratome is also used in Descemet's stripping automated endothelial keratoplasty (DSAEK), where it is used to slice a thin layer from the back of the donor cornea, which is then transplanted into the posterior cornea of the recipient. It was invented by Jose Barraquer and Cesar Carlos Carriazo in the 1950s in Colombia.
Eye surgery, also known as ophthalmic surgery or ocular surgery, is surgery performed on the eye or its adnexa. Eye surgery is part of ophthalmology and is performed by an ophthalmologist or eye surgeon. The eye is a fragile organ, and requires due care before, during, and after a surgical procedure to minimize or prevent further damage. An eye surgeon is responsible for selecting the appropriate surgical procedure for the patient, and for taking the necessary safety precautions. Mentions of eye surgery can be found in several ancient texts dating back as early as 1800 BC, with cataract treatment starting in the fifth century BC. It continues to be a widely practiced class of surgery, with various techniques having been developed for treating eye problems.
Radial keratotomy (RK) is a refractive surgical procedure to correct myopia (nearsightedness). It was developed in 1974 by Svyatoslav Fyodorov, a Russian ophthalmologist. It has been largely supplanted by newer, more accurate operations, such as photorefractive keratectomy, LASIK, Epi-LASIK and the phakic intraocular lens.
Refractive surgery is an optional eye surgery used to improve the refractive state of the eye and decrease or eliminate dependency on glasses or contact lenses. This can include various methods of surgical remodeling of the cornea (keratomileusis), lens implantation or lens replacement. The most common methods today use excimer lasers to reshape the curvature of the cornea. Refractive eye surgeries are used to treat common vision disorders such as myopia, hyperopia, presbyopia and astigmatism.
Corneal transplantation, also known as corneal grafting, is a surgical procedure where a damaged or diseased cornea is replaced by donated corneal tissue. When the entire cornea is replaced it is known as penetrating keratoplasty and when only part of the cornea is replaced it is known as lamellar keratoplasty. Keratoplasty simply means surgery to the cornea. The graft is taken from a recently deceased individual with no known diseases or other factors that may affect the chance of survival of the donated tissue or the health of the recipient.
José Ignacio Barraquer Moner was a Spanish ophthalmologist and inventor born in Barcelona who did most of his life's work in Bogotá, Colombia.
Pellucid marginal degeneration (PMD) is a degenerative corneal condition, often confused with keratoconus. It typically presents with painless vision loss affecting both eyes. Rarely, it may cause acute vision loss with severe pain due to perforation of the cornea. It is typically characterized by a clear, bilateral thinning (ectasia) in the inferior and peripheral region of the cornea, although some cases affect only one eye. The cause of the disease remains unclear.
Peter S. Hersh is an American ophthalmologist, researcher, and specialist in LASIK eye surgery, keratoconus, and diseases of the cornea. He co-authored the article in the journal Ophthalmology that presented the results of the study that led to the first approval by the U.S. Food and Drug Administration (FDA) of the excimer laser for the correction of nearsightedness in the United States. Hersh was also medical monitor of the study that led to approval of corneal collagen crosslinking for the treatment of keratoconus. He was the originator, in 2015, of CTAK for keratoconus, patent holder, and co-developer.
Raymond Mark Stein, MD, FRCSC, DABO, is a Canadian ophthalmologist. He practices refractive and cataract surgery. He is the medical director of the Bochner Eye Institute in Toronto, Ontario and Chief of Ophthalmology at the Scarborough General Hospital.
Jeewan Singh Titiyal is an Indian ophthalmologist, credited with the first live cornea transplant surgery by an Indian doctor. He was honoured by the Government of India, in 2014, by bestowing on him the Padma Shri, the fourth highest civilian award, for his services to the field of medicine.
Seyed Hassan Ghazizadeh Hashemi is an ophthalmologist and full professor at Tehran University of Medical Sciences, as well as the head and founder of the Noor Ophthalmology Complex.
Dr Amar Agarwal M.S., FRCS, F.R.C.Ophth is an Indian ophthalmologist and chairman and managing director of Dr. Agarwal's Eye Hospital and Eye Research Centre in India, which includes 190 + eye hospitals. He is the recipient of the Best Doctor award of the State government from then Chief Minister of Tamil Nadu J Jayalalithaa on 15 August 2014. He is also the past President of the International Society of Refractive Surgery (ISRS) and Secretary General of the Intraocular Implant and Refractive Society of India (IIRSI).
Farhad Hafezi is a prominent Swiss eye surgeon and researcher. Hafezi first gained recognition as a leading retina researcher in 1994, having been the first to discover a gene responsible for light-induced retinal degeneration. However, he changed his research focus to the cornea in 2003, and it is this work, particularly on corneal collagen cross-linking (CXL), which he helped pioneer, and advanced laser refractive surgery that he is internationally known for today. Hafezi's current clinical and laboratory research is focused on gaining a better understanding of the cornea. His research group at the University of Zurich has three main research foci:
Noel Alpins is an Australian ophthalmologist who developed the Alpins method of astigmatism analysis used in refractive, corneal, and cataract surgery, used in the research of LASIK.
Allon Barsam is a London-based ophthalmologist specializing in cataract surgery, refractive surgery and corneal and external eye disease. Barsam carried out the first human treatments of microwave keratoplasty.
Herbert Edward Kaufman is an American ophthalmologist who discovered idoxuridine, the first clinically useful antiviral agent; co-developed with William Bourne the clinical specular microscope to view the live corneal endothelium, co-developed timolol with Thomas Zimmerman, a new class of medications to treat glaucoma; corneal storage media for eye banks; natamycin, the first commercially available medication to treat fungal infections of the eye; co-developed with Tony Gasset the use of bandage contact lenses; and was involved in the first laser vision photorefractive keratectomy of the eye with Marguarite McDonald.
Anastasios John Kanellopoulos is a Greek-American eye surgeon specializing in corneal transplantation, cornea crosslinking for keratoconus, complicated cataract surgery and complicated glaucoma. Widely known for research and clinical contributions in micro-incision cataract, customized laser refractive surgery and corneal cross-linking propagation and most innovations, reducing corneal transplants for advanced keratoconus.